View : 739 Download: 0
Prognostic significance of CD44s expression in biliary tract cancers
- Title
- Prognostic significance of CD44s expression in biliary tract cancers
- Authors
- Lee S.M.; Lee K.E.; Chang H.J.; Choi M.Y.; Cho M.-S.; Min S.K.; Lee H.K.; Mun Y.C.; Nam E.M.; Seong C.M.; Lee S.N.
- Ewha Authors
- 이순남; 성주명; 조민선; 이현국; 민석기; 이경은; 문영철; 남은미
- SCOPUS Author ID
- 이순남; 성주명; 조민선; 이현국; 민석기; 이경은; 문영철; 남은미
- Issue Date
- 2008
- Journal Title
- Annals of Surgical Oncology
- ISSN
- 1068-9265
- Citation
- Annals of Surgical Oncology vol. 15, no. 4, pp. 1155 - 1160
- Indexed
- SCI; SCIE; SCOPUS
- Document Type
- Conference Paper
- Abstract
- Background: CD44 is an essential surface glycoprotein component of the hyaluronan receptor and is associated with adhesion and metastasis in many solid tumors. There are several isoforms of CD44, including CD44 standard (CD44s) and 10 CD44 variants (CD44v1 to CD44v10). We evaluated the clinical significance of CD44s and CD44v6 in biliary tract cancers. Methods: Patients who had been diagnosed with primary biliary tract cancers were enrolled onto the study, and tissue specimens were obtained during surgery. Paraffin-embedded tissue sections were evaluated for the presence of CD44s and CD44v6 by immunohistochemical staining. We decided CD44s and CD44v6 expression as overexpression, which shows an intensity grade of >10%. Clinical data of all patients were reviewed. Results: Ninety-five patients (35 men and 60 women; median age, 64 years; range, 37-86 years) were evaluated. The incidence of overexpression (>10%) of CD44s was 49%, and that of CD44v6 was 17%. The median postoperative follow-up duration was 34.3 months, and the median overall survival was 12.2 months. The Cox proportional hazard ratio (HR) test identified CD44s overexpression (0% to 10% vs. 10% to 100%; HR, .420; 95% confidence interval [95% CI], .211-.837; P = .014) and cancer stage as prognostic factors. However, the expression of CD44v6 (0% to 10% vs. 10% to 100%; HR, 1.462; 95% CI, .630-3.393; P = .377) had no prognostic significance for survival. Conclusions: CD44s overexpression is useful as a marker of a poor prognosis for biliary tract cancer. Aggressive postoperative therapy should be considered for such patients. © 2008 Society of Surgical Oncology.
- DOI
- 10.1245/s10434-007-9786-9
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML